The Role of Opioid-Sparing Anesthesia and Analgesia Strategies in Urological Surgery

Background: Opioid-sparing anesthesia and analgesia are being increasingly incorporated into perioperative care in urological surgery because of concerns regarding opioid-related adverse effects and the need to facilitate early postoperative recovery.Objective: The aim of this narrative review was to summarize recent evidence regarding the effectiveness, safety, and clinical applicability of opioid-sparing and multimodal analgesic strategies in adult patients undergoing urological procedures, with particular attention to the pharmacological and regional techniques used during the intraoperative and postoperative periods.Materials and Methods: A narrative literature review was conducted using the PubMed and Cochrane Library databases. Publications from 2021 to 2026 were considered. The search strategy included combinations of the terms ‘opioid-sparing anesthesia’, ‘opioid-free anesthesia’, ‘multimodal analgesia’, ‘enhanced recovery after surgery’, ‘postoperative pain’, and ‘opioids’, combined with urology-related terms such as ‘urology’, ‘nephrectomy’, ‘prostatectomy’, ‘cystectomy’, and ‘ureteroscopy’. Following the application of publication type filters, 111 records were identified in PubMed and 159 in the Cochrane Library. After assessment of relevance and eligibility, 25 publications were included in the narrative synthesis. The selected literature comprised randomized controlled trials, observational studies, systematic reviews, meta-analyses, and guidelines addressing perioperative analgesic management and opioid-reduction strategies in urological surgery.Results: The available evidence indicates that multimodal opioid-sparing strategies can reduce opioid exposure at different stages of perioperative care while maintaining adequate postoperative analgesia in several urological procedures. The evaluated approaches differed in their timing and components: some studies investigated intraoperative opioid-sparing anesthesia using agents such as ketamine, esketamine, dexmedetomidine, and lidocaine, whereas others focused on postoperative analgesia, opioid prescribing, or regional techniques. Urology-specific studies demonstrated that non-opioid multimodal regimens can provide pain control comparable to opioid-based approaches after robot-assisted radical prostatectomy, while opioid-limiting protocols may reduce opioid use after transurethral resection of the prostate. Regional techniques, including transversus abdominis plane (TAP), quadratus lumborum (QL), and erector spinae plane (ESP) blocks, as well as local anesthetic infiltration, may further reduce early postoperative pain and opioid requirements. Evidence concerning dexmedetomidine, ketamine, and other non-opioid agents suggests potential opioid-sparing effects in selected urological procedures, although the available evidence remains heterogeneous across surgical settings and analgesic protocols. Opioid reduction may also be associated with less nausea and vomiting, earlier functional recovery, and reduced opioid prescribing at discharge. However, current evidence does not demonstrate consistent superiority of complete opioid-free anesthesia over individualized opioid-sparing strategies, particularly for procedures associated with substantial postoperative pain.Conclusions: Opioid-sparing multimodal analgesia represents a useful component of perioperative care in urological surgery. The available evidence supports reducing unnecessary opioid exposure through combinations of systemic non-opioid medications, regional anesthesia techniques, and individualized rescue analgesia. Interpretation of the findings requires consideration of whether the investigated interventions were administered intraoperatively, postoperatively, or throughout the perioperative period. The optimal analgesic regimen should be individualized according to the surgical procedure, expected pain intensity, comorbidities, previous opioid exposure, and contraindications to individual analgesic agents. Complete opioid avoidance should not be considered an obligatory endpoint, and a limited amount of rescue opioid therapy may remain appropriate when clinically indicated. Further procedure-specific randomized trials are required to establish optimal combinations and dosing strategies.

Authors

Institutions

Publication Details

Journal
Acta medica Lituanica
Published
2026-11-20
DOI
https://doi.org/10.15388/amed.2026.33.2.26
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Role of Opioid-Sparing Anesthesia and Analgesia Strategies in Urological Surgery

Barbora Jociutė, Kristina Mačionienė
3 links
Acta medica Lituanica
Anesthesia and Pain Management
article

The Role of Opioid-Sparing Anesthesia and Analgesia Strategies in Urological Surgery

Barbora Jociutė, Kristina Mačionienė
article en

Abstract

Background: Opioid-sparing anesthesia and analgesia are being increasingly incorporated into perioperative care in urological surgery because of concerns regarding opioid-related adverse effects and the need to facilitate early postoperative recovery.Objective: The aim of this narrative review was to summarize recent evidence regarding the effectiveness, safety, and clinical applicability of opioid-sparing and multimodal analgesic strategies in adult patients undergoing urological procedures, with particular attention to the pharmacological and regional techniques used during the intraoperative and postoperative periods.Materials and Methods: A narrative literature review was conducted using the PubMed and Cochrane Library databases. Publications from 2021 to 2026 were considered. The search strategy included combinations of the terms ‘opioid-sparing anesthesia’, ‘opioid-free anesthesia’, ‘multimodal analgesia’, ‘enhanced recovery after surgery’, ‘postoperative pain’, and ‘opioids’, combined with urology-related terms such as ‘urology’, ‘nephrectomy’, ‘prostatectomy’, ‘cystectomy’, and ‘ureteroscopy’. Following the application of publication type filters, 111 records were identified in PubMed and 159 in the Cochrane Library. After assessment of relevance and eligibility, 25 publications were included in the narrative synthesis. The selected literature comprised randomized controlled trials, observational studies, systematic reviews, meta-analyses, and guidelines addressing perioperative analgesic management and opioid-reduction strategies in urological surgery.Results: The available evidence indicates that multimodal opioid-sparing strategies can reduce opioid exposure at different stages of perioperative care while maintaining adequate postoperative analgesia in several urological procedures. The evaluated approaches differed in their timing and components: some studies investigated intraoperative opioid-sparing anesthesia using agents such as ketamine, esketamine, dexmedetomidine, and lidocaine, whereas others focused on postoperative analgesia, opioid prescribing, or regional techniques. Urology-specific studies demonstrated that non-opioid multimodal regimens can provide pain control comparable to opioid-based approaches after robot-assisted radical prostatectomy, while opioid-limiting protocols may reduce opioid use after transurethral resection of the prostate. Regional techniques, including transversus abdominis plane (TAP), quadratus lumborum (QL), and erector spinae plane (ESP) blocks, as well as local anesthetic infiltration, may further reduce early postoperative pain and opioid requirements. Evidence concerning dexmedetomidine, ketamine, and other non-opioid agents suggests potential opioid-sparing effects in selected urological procedures, although the available evidence remains heterogeneous across surgical settings and analgesic protocols. Opioid reduction may also be associated with less nausea and vomiting, earlier functional recovery, and reduced opioid prescribing at discharge. However, current evidence does not demonstrate consistent superiority of complete opioid-free anesthesia over individualized opioid-sparing strategies, particularly for procedures associated with substantial postoperative pain.Conclusions: Opioid-sparing multimodal analgesia represents a useful component of perioperative care in urological surgery. The available evidence supports reducing unnecessary opioid exposure through combinations of systemic non-opioid medications, regional anesthesia techniques, and individualized rescue analgesia. Interpretation of the findings requires consideration of whether the investigated interventions were administered intraoperatively, postoperatively, or throughout the perioperative period. The optimal analgesic regimen should be individualized according to the surgical procedure, expected pain intensity, comorbidities, previous opioid exposure, and contraindications to individual analgesic agents. Complete opioid avoidance should not be considered an obligatory endpoint, and a limited amount of rescue opioid therapy may remain appropriate when clinically indicated. Further procedure-specific randomized trials are required to establish optimal combinations and dosing strategies.

Acta medica LituanicaVol. 33(2)
Lithuanian University of Health Sciences (LT)
Good health and well-being
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon